Interferon-γ responses after isoniazid chemotherapy for latent tuberculosis

Respirology

Volumn 13, Issue 3, 2008, Pages 468-472

  Higuchi, Kazue ^a   Harada, Nobuyuki ^a   Mori, Toru ^b  

^a RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Chemotherapy; Isoniazid; QuantiFERON TB Gold; Tuberculosis

Indexed keywords

CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; ISONIAZID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; HUMAN; LIVER DYSFUNCTION; MENTAL HOSPITAL; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

ADULT; AGED; ANTITUBERCULAR AGENTS; BIOLOGICAL MARKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INTERFERON TYPE II; ISONIAZID; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS; VIRUS LATENCY;

EID: 41849085514     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2008.01244.x     Document Type: Article

References (23)

1. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune based diagnosis of tuberculosis. Lancet 2000 356 : 1099 104.
2. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y et al. Specific detection of tuberculosis infection. An interferon-γ-based assay using new antigens. Am. J. Respir. Crit. Care Med. 2004 170 : 59 64.
3. ®TB-2G, in an outbreak of tuberculosis. Kekkaku 2004 79 : 637 43 (in Japanese with English abstract, tables and figures).
4. Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am. J. Respir. Crit. Care Med. 2004 170 : 65 9.
5. Kang YA, Lee HW, Yoon HI, Cho B, Han SK et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005 293 : 2756 61.
6. ®TB-2G in contact investigation of a tuberculosis outbreak in a University. Kekkaku 2005 80 : 527 34 (in Japanese with English abstract, tables and figures).
7. ®TB-2G. Kekkaku 2005 80 : 557 64 (in Japanese with English abstract, tables and figures).
8. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J et al. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect. Control Hosp. Epidemiol. 2006 27 : 442 8.
9. Diel R, Nienhaus A, Lange C, Meywald-Walter K, Forssbohm M et al. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir. Res. 2006 7 : 77.
10. Pathan AA, Wilkinson KA, Klenerman P, McShane H, Davidson RN et al. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J. Immunol. 2001 167 : 5217 25.
11. Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E et al. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin. Infect. Dis. 2004 38 : 754 6.
12. Nicol MP, Pienaar D, Wood K, Eley B, Wilkinson RJ et al. Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin. Infect. Dis. 2005 40 : 1301 8.
13. Aiken AM, Hill PC, Fox A, McAdam KP, Jackson-Sillah DJ et al. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect. Dis. 2006 6 : 66.
14. Wilkinson KA, Kon OM, Newton SM, Meintjes G, Davidson RN et al. Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. J. Infect. Dis. 2006 193 : 354 9.
15. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P et al. Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J. Occup. Med. Toxicol. 2006 1 : 7.
16. Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G et al. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 2006 174 : 831 9.
17. Chee CB, Khinmar KW, Gan SH, Barkham TM, Pushparani M et al. Latent tuberculosis infection treatment and T-cell responses to M. tuberculosis- specific antigens. Am. J. Respir. Crit. Care Med. 2007 175 : 282 7.
18. Goletti D, Parracino MP, Butera O, Bizzoni F, Casetti R et al. Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study. Respir. Res. 2007 8 : 5.
19. Maeda M, Asami N, Murohashi T. Further studies on the potency of purified protein derivatives of tuberculin (PPD-s). 1st Report. Comparison of the potency of three preparations of PPD. Kekkaku 1960 35 : 563 6 (in Japanese).
20. Kimura M, Comstock GL, Mori T. Comparison of erythema and induration as results of tuberculin tests. Int. J. Tuberc. Lung Dis. 2005 9 : 853 7.
21. Ministry of Health, Labour and Welfare. Tuberculosis treatment standards (in Japanese). Ministry of Health, Labour and Welfare Bull. 2004 238.
22. Dheda K, Udwadia ZF, Huggett JF, Johnson MA, Rook GA. Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis. Curr. Opin. Pulm. Med. 2005 11 : 195 202.
23. Andersen P, Doherty TM, Pai M, Weldingh K. The prognosis of latent tuberculosis: can disease be predicted? Trends Mol. Med. 2007 13 : 175 82.